Biotech Ap S Wg is Director of Y-mAbs Therapeutics, Inc.. Currently has a direct ownership of 4.56 Million shares of YMAB, which is worth approximately $67.8 Million. The most recent transaction as insider was on Dec 11, 2023, when has been sold 6,455 shares (Common Stock) at a price of $6.85 per share, resulting in proceeds of $44,216. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 4.56M
0% 3M change
6.52% 12M change
Total Value Held $67.8 Million

Biotech ApS WG Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 11 2023
BUY
Open market or private purchase
$44,216 $6.85 p/Share
6,455 Added 0.14%
4,559,233 Common Stock
Dec 11 2023
BUY
Open market or private purchase
$721,069 $7.01 p/Share
102,863 Added 2.21%
4,552,778 Common Stock
Dec 08 2023
BUY
Open market or private purchase
$129,335 $6.99 p/Share
18,503 Added 0.41%
4,449,915 Common Stock
Dec 07 2023
BUY
Open market or private purchase
$40,189 $6.5 p/Share
6,183 Added 0.14%
4,431,412 Common Stock
Nov 29 2023
BUY
Open market or private purchase
$309,466 $5.97 p/Share
51,837 Added 1.16%
4,425,229 Common Stock
Nov 28 2023
BUY
Open market or private purchase
$178,198 $5.81 p/Share
30,671 Added 0.7%
4,373,392 Common Stock
Nov 27 2023
BUY
Open market or private purchase
$343,212 $5.49 p/Share
62,516 Added 1.42%
4,342,721 Common Stock
May 15 2023
BUY
Open market or private purchase
$981,791 $9.65 p/Share
101,740 Added 2.32%
4,280,205 Common Stock
Jun 10 2021
SELL
Open market or private sale
$405,928 $36.15 p/Share
11,229 Reduced 0.27%
4,178,456 Common Stock
Jun 09 2021
SELL
Open market or private sale
$4,223,373 $36.19 p/Share
116,700 Reduced 2.71%
4,189,694 Common Stock
Jun 08 2021
SELL
Open market or private sale
$1,174,824 $35.28 p/Share
33,300 Reduced 0.77%
4,306,394 Common Stock
Jun 07 2021
SELL
Open market or private sale
$2,472,460 $34.15 p/Share
72,400 Reduced 1.64%
4,339,694 Common Stock
Jun 04 2021
SELL
Open market or private sale
$130,709 $34.03 p/Share
3,841 Reduced 0.09%
4,412,094 Common Stock
Jun 03 2021
SELL
Open market or private sale
$1,017,804 $33.19 p/Share
30,666 Reduced 0.69%
4,415,935 Common Stock
Jun 01 2021
SELL
Open market or private sale
$244,152 $35.57 p/Share
6,864 Reduced 0.15%
4,446,601 Common Stock
May 28 2021
SELL
Open market or private sale
$908,500 $36.34 p/Share
25,000 Reduced 0.56%
4,453,465 Common Stock
BAW

Biotech Ap S Wg

Director
Rungsted Kyst, G7

Track Institutional and Insider Activities on YMAB

Follow Y-mAbs Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells YMAB shares.

Notify only if

Insider Trading

Get notified when an Y M Abs Therapeutics, Inc. insider buys or sells YMAB shares.

Notify only if

News

Receive news related to Y-mAbs Therapeutics, Inc.

Track Activities on YMAB